Kim J, Hasegawa T, Tada K, Uehara Y, Fukui Y, Nakamura A
Ann Dermatol. 2023; 35(Suppl 1):S63-S66.
PMID: 37853868
PMC: 10608360.
DOI: 10.5021/ad.21.077.
Athni T, Barmettler S
Ann Allergy Asthma Immunol. 2023; 130(6):699-712.
PMID: 36706910
PMC: 10247428.
DOI: 10.1016/j.anai.2023.01.018.
Davis J, Ferreira D, Paige E, Gedye C, Boyle M
Clin Microbiol Rev. 2020; 33(3).
PMID: 32522746
PMC: 7289788.
DOI: 10.1128/CMR.00035-19.
Parikh A, Vinnard C, Fahrenfeld N, Davidow A, Patrawalla A, Lardizabal A
Int J Environ Res Public Health. 2019; 16(21).
PMID: 31683836
PMC: 6862550.
DOI: 10.3390/ijerph16214250.
Khoo T, Limaye V
Rheumatol Int. 2019; 40(2):191-205.
PMID: 31680207
DOI: 10.1007/s00296-019-04467-6.
Functional Analysis of Anti-cytokine Autoantibodies Using Flow Cytometry.
Merkel P, Lebo T, Knight V
Front Immunol. 2019; 10:1517.
PMID: 31354706
PMC: 6640114.
DOI: 10.3389/fimmu.2019.01517.
Miliary tuberculosis mimicking systemic lupus erythematosus flare.
Elzein F, Elzein A, Mohammed N, Alswailem R
Respir Med Case Rep. 2018; 25:216-219.
PMID: 30237973
PMC: 6143694.
DOI: 10.1016/j.rmcr.2018.09.005.
Infectious complications of rituximab therapy in renal disease.
Nixon A, Ogden L, Woywodt A, Dhaygude A
Clin Kidney J. 2017; 10(4):455-460.
PMID: 28852481
PMC: 5570071.
DOI: 10.1093/ckj/sfx038.
A Case of an Enigmatic Pulmonary Infiltrate.
Ibrahim U, Saqib A, Chalhoub M, Atallah J
Cureus. 2016; 8(10):e828.
PMID: 27882275
PMC: 5106207.
DOI: 10.7759/cureus.828.
Risk Factors and Outcomes of Nontuberculous Mycobacterial Disease among Rheumatoid Arthritis Patients: A Case-Control study in a TB Endemic Area.
Liao T, Lin C, Chen Y, Liu H, Chen D
Sci Rep. 2016; 6:29443.
PMID: 27404002
PMC: 4941402.
DOI: 10.1038/srep29443.
Syndrome of selective IgM deficiency with severe T cell deficiency associated with disseminated cutaneous mycobacterium avium intracellulaire infection.
Gharib A, Louis A, Agrawal S, Gupta S
Am J Clin Exp Immunol. 2015; 4(2):15-27.
PMID: 26550546
PMC: 4620120.
B Cell Therapies, Approved and Emerging: a Review of Infectious Risk and Prevention During Use.
Md Yusof M, Vital E, Buch M
Curr Rheumatol Rep. 2015; 17(10):65.
PMID: 26290110
DOI: 10.1007/s11926-015-0539-7.
Nontuberculous mycobacteria infections in immunosuppressed hosts.
Henkle E, Winthrop K
Clin Chest Med. 2015; 36(1):91-9.
PMID: 25676522
PMC: 4710582.
DOI: 10.1016/j.ccm.2014.11.002.
Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy.
Winthrop K, Iseman M
Nat Rev Rheumatol. 2013; 9(9):524-31.
PMID: 23797309
DOI: 10.1038/nrrheum.2013.82.
Systemic granulomatous reaction secondary to treatment of bladder cancer with bacillus calmette-guerin.
Valentini C, Bozzoli V, Larici A, Larocca L, Delogu G, Leone G
Mediterr J Hematol Infect Dis. 2012; 4(1):e2012040.
PMID: 22811789
PMC: 3395695.
DOI: 10.4084/MJHID.2012.040.
Does rituximab increase the incidence of infectious complications? A narrative review.
Kelesidis T, Daikos G, Boumpas D, Tsiodras S
Int J Infect Dis. 2010; 15(1):e2-16.
PMID: 21074471
PMC: 8053444.
DOI: 10.1016/j.ijid.2010.03.025.
[Anti-B-cell strategies in vasculitides and collagenoses].
Rubbert-Roth A
Z Rheumatol. 2009; 68(5):390-6.
PMID: 19551392
DOI: 10.1007/s00393-009-0439-1.